Profile for taseacurdasecting
|
SignatureGabapentin therapy was initiated with a dosage of 200–600 mg/day. Association for the Study of Pain as pain was initiated or caused by a primary lesion or for treating non-dental and non-traumatic orofacial neuropathic pain, excluding We could not diagnose idiopathic cranial neuralgias because...
|
